Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Dec;56(12):6430-1.
doi: 10.1128/AAC.01787-12. Epub 2012 Oct 1.

A case of daptomycin-induced immune thrombocytopenia

Affiliations
Case Reports

A case of daptomycin-induced immune thrombocytopenia

Charles Grégoire et al. Antimicrob Agents Chemother. 2012 Dec.

Abstract

We report a case of severe daptomycin-induced immune thrombocytopenia in a patient treated for methicillin-resistant Staphylococcus epidermidis and ampicillin-resistant Enterococcus faecalis bacteremia acquired in an intensive care unit. Serum antibodies bound to platelets in the presence of daptomycin on flow cytometry. There was no evidence of other causes of thrombocytopenia. The patient died of brain herniation complicating extensive cerebral hemorrhage. To our knowledge, this is the first described case of daptomycin-induced thrombocytopenia.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Flow cytometry analysis for the presence of a daptomycin-dependent, platelet-reactive antibody. The platelet median fluorescence intensity (MFI) was significantly higher with the patient's serum plus daptomycin (MFI, 4,325) than with the patient's serum plus buffer (MFI, 1,494) or normal serum plus daptomycin (MFI, 1,829). No such difference occurred with piperacillin-tazobactam (left).

References

    1. Aster RH, Bougie DW. 2007. Drug-induced immune thrombocytopenia. N. Engl. J. Med. 357:580–587 - PubMed
    1. Bougie DW, Wilker PR, Aster RH. 2006. Patients with quinine-induced immune thrombocytopenia have both “drug-dependent” and “drug-specific” antibodies. Blood 108:922–927 - PMC - PubMed
    1. Carpenter CF, Chambers HF. 2004. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin. Infect. Dis. 38:994–1000 - PubMed
    1. Moore CL, et al. 2012. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study. Clin. Infect. Dis. 54:51–58 - PubMed
    1. Rousan TA, et al. 2010. Recurrent acute thrombocytopenia in the hospitalized patient: sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia. Am. J. Hematol. 85:71–74 - PMC - PubMed

Publication types

MeSH terms